Gritstone Bio Analyst Ratings
Gritstone Bio Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
02/15/2023 | 162.17% | HC Wainwright & Co. | → $7 | Maintains | Buy |
11/07/2022 | 162.17% | HC Wainwright & Co. | $12 → $7 | Maintains | Buy |
10/31/2022 | 124.72% | Piper Sandler | → $6 | Initiates Coverage On | → Overweight |
08/22/2022 | -25.09% | Goldman Sachs | → $2 | Downgrades | Neutral → Sell |
05/09/2022 | 349.44% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
03/14/2022 | 461.8% | HC Wainwright & Co. | $24 → $15 | Maintains | Buy |
01/20/2021 | 199.63% | Baird | → $8 | Downgrades | Outperform → Underperform |
01/20/2021 | 798.88% | HC Wainwright & Co. | $16 → $24 | Maintains | Buy |
07/14/2020 | 536.7% | BTIG | $31 → $17 | Maintains | Buy |
07/26/2019 | 536.7% | Baird | → $17 | Initiates Coverage On | → Outperform |
03/15/2019 | 649.06% | Raymond James | → $20 | Initiates Coverage On | → Outperform |
03/07/2019 | 536.7% | HC Wainwright & Co. | → $17 | Initiates Coverage On | → Buy |
10/23/2018 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
10/23/2018 | 574.16% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
10/23/2018 | 873.78% | BTIG | → $26 | Initiates Coverage On | → Buy |
10/23/2018 | 836.33% | Barclays | → $25 | Initiates Coverage On | → Overweight |
日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
---|---|---|---|---|---|
02/15/2023 | 162.17% | HC 溫賴特 & 有限公司. | → 7 美元 | 維護 | 購買 |
11/07/2022 | 162.17% | HC 溫賴特 & 有限公司. | 十二美元 → 7 美元 | 維護 | 購買 |
2022 年 10 月 31 日 | 124.72% | 吹笛者桑德勒 | → 6 美元 | 啟動覆蓋範圍 | → 超重 |
2022 年 08 月 22 日 | -25.09% | 高盛 | → 2 美元 | 降級 | 中性 → 賣出 |
2022 年 9 月 5 日 | 349.44% | HC 溫賴特 & 有限公司. | 15 美元 → 12 美元 | 維護 | 購買 |
03/14/2022 | 461.8% | HC 溫賴特 & 有限公司. | 二十四元 → 15 美元 | 維護 | 購買 |
01/20/2021 | 199.63% | 貝爾德 | → 8 美元 | 降級 | 跑贏大市 → 跑贏大市 |
01/20/2021 | 798.88% | HC 溫賴特 & 有限公司. | 十六美元 → 二十四美元 | 維護 | 購買 |
07/14/2020 | 536.7% | BTIG | 三十一美元 → 17 美元 | 維護 | 購買 |
07/26/2019 | 536.7% | 貝爾德 | → 17 美元 | 啟動覆蓋範圍 | → 跑贏大市 |
03/15/2019 | 649.06% | 雷蒙詹姆斯 | → 20 美元 | 啟動覆蓋範圍 | → 跑贏大市 |
03/07/2019 | 536.7% | HC 溫賴特 & 有限公司. | → 17 美元 | 啟動覆蓋範圍 | → 購買 |
10/23/2018 | — | 科恩 & 有限公司. | 啟動覆蓋範圍 | → 跑贏大市 | |
10/23/2018 | 574.16% | 高盛 | → 18 美元 | 啟動覆蓋範圍 | → 中性 |
10/23/2018 | 873.78% | BTIG | → 二十六美元 | 啟動覆蓋範圍 | → 購買 |
10/23/2018 | 836.33% | 巴克萊 | → 25 美元 | 啟動覆蓋範圍 | → 超重 |
What is the target price for Gritstone Bio (GRTS)?
格里斯通生物(GRTS)的目標價格是多少?
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by HC Wainwright & Co. on February 15, 2023. The analyst firm set a price target for $7.00 expecting GRTS to rise to within 12 months (a possible 162.17% upside). 6 analyst firms have reported ratings in the last year.
格里斯通生物(納斯達克股票代碼:GRTS)的最新價格目標是由溫賴特有限公司於 2023 年 2 月 15 日報導。該分析師公司設定了 7.00 美元的價格目標,預計 GRTS 將在 12 個月內上升至(可能上漲 162.17%)。去年有 6 家分析師公司報告了評級。
What is the most recent analyst rating for Gritstone Bio (GRTS)?
格里斯通生物 (GRTS) 的最新分析師評級為何?
The latest analyst rating for Gritstone Bio (NASDAQ: GRTS) was provided by HC Wainwright & Co., and Gritstone Bio maintained their buy rating.
格里斯通生物(納斯達克股票代碼:GRTS)的最新分析師評級由 HC 溫賴特公司提供,格里斯通生物保持其購買評級。
When is the next analyst rating going to be posted or updated for Gritstone Bio (GRTS)?
格里斯通生物(GRTS)的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gritstone Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gritstone Bio was filed on February 15, 2023 so you should expect the next rating to be made available sometime around February 15, 2024.
分析師在做廣泛的研究後到達股票評級,其中包括通過公共財務報表,與 Gritstone Bio 的高管和客戶交談,並聽取盈利電話會議。大多數分析師每三個月這樣做一次,因此您應該每年每家公司獲得 4 個評級。格里斯通生物的最後評級提交 2 月 15, 2023 所以你應該期望下一個評級將在 2 月左右的某個時候提供 15, 2024.
Is the Analyst Rating Gritstone Bio (GRTS) correct?
分析師評級格里斯通生物(GRTS)是否正確?
While ratings are subjective and will change, the latest Gritstone Bio (GRTS) rating was a maintained with a price target of $0.00 to $7.00. The current price Gritstone Bio (GRTS) is trading at is $2.67, which is within the analyst's predicted range.
雖然評級是主觀的並且會發生變化,但最新的格里斯通生物(GRTS)評級保持,目標價格為 0.00 美元至 7.00 美元。當前價格里茨通生物(GRTS)的交易價格為 2.67 美元,這在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。